Back to Market Feed

EPIVIR 300 MG TABLET

lamivudine
$13.2940per EA
High Outlier

Strength

300 mg/1

NDC

49702020413

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/22/2014

Active Ingredients

LAMIVUDINE

Approval Type

New Drug (NDA)

FDA Application

NDA020564

On Market Since

10/4/2010

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-0.3%

Generic Alternatives

Save up to 90%

1 alternative • Same active ingredient

LAMIVUDINE 300 MG TABLET
Generic
60505325203•Apotex Corp.
$1.2918
Save 90%

Related Drugs

Same classification

ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
EMTRIVA 200 MG CAPSULE
Brand
61958060101•Gilead Sciences, Inc.
$17.4370
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.2861
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7318
per EA
BARACLUDE 1 MG TABLET
Brand
00003161212•E.R. Squibb & Sons, L.L.C.
$43.9221
per EA
BARACLUDE 0.5 MG TABLET
Brand
00003161112•E.R. Squibb & Sons, L.L.C.
$44.1865
per EA
EDURANT 25 MG TABLET
Brand
59676027801•Janssen Products LP
$48.1197
per EA
VEMLIDY 25 MG TABLET
Brand
61958230101•Gilead Sciences, Inc.
$51.9338
per EA